US Stock MarketDetailed Quotes

Xeris Pharmaceuticals (XERS)

Watchlist
  • 6.710
  • +0.210+3.23%
Close Jun 10 15:59 ET
  • 6.541
  • -0.169-2.52%
Post 19:57 ET
1.16BMarket Cap91.92P/E (TTM)

Xeris Pharmaceuticals (XERS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
198.39%9.87M
177.41%28.63M
914.84%20.04M
321.94%18.43M
101.76%182K
50.59%-10.03M
21.36%-36.98M
-73.56%1.98M
43.16%-8.31M
24.71%-10.35M
Net income from continuing operations
124.23%2.23M
101.01%554K
316.72%11.08M
103.95%621K
87.15%-1.93M
51.42%-9.22M
11.92%-54.84M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
Operating gains losses
----
----
----
----
----
----
-97.07%83K
----
----
----
Depreciation and amortization
2.13%3.21M
0.54%12.69M
2.04%3.2M
2.08%3.19M
0.32%3.16M
-2.21%3.14M
-4.07%12.63M
-3.87%3.13M
-6.94%3.12M
-6.21%3.15M
Deferred tax
----
--0
--0
--0
--0
--0
-81.59%-2.27M
--0
-592.44%-3.32M
210.96%749K
Other non cash items
5.33%889K
359.86%3.37M
-4.52%866K
120.10%843K
298.06%820K
130.21%844K
51.48%-1.3M
170.80%907K
206.09%383K
192.79%206K
Change In working capital
93.47%-603K
-17.46%-10.36M
21.31%-373K
810.39%6.14M
-103.19%-6.88M
-64.05%-9.24M
-40.13%-8.82M
-102.71%-474K
106.08%674K
-398.68%-3.39M
-Change in receivables
11.33%-5.25M
-773.15%-10.64M
273.58%2.7M
-153.99%-703K
-33.66%-6.72M
-431.74%-5.92M
85.44%-1.22M
-89.32%723K
108.27%1.3M
-891.50%-5.03M
-Change in inventory
123.53%851K
-119.61%-19.29M
-27.86%-4.01M
-289.79%-4.09M
-234.35%-7.57M
-55.10%-3.62M
40.68%-8.78M
-123.91%-3.14M
51.32%-1.05M
69.53%-2.27M
-Change in prepaid assets
-90.54%145K
-25.34%-2.1M
502.89%1.25M
-2,496.74%-5.15M
-3.91%270K
182.51%1.53M
-152.18%-1.67M
-115.28%-311K
-37.32%215K
-86.31%281K
-Change in payables and accrued expense
414.01%9.01M
1,062.43%19.62M
-143.05%-1.98M
880.17%16.76M
1,021.66%7.72M
44.65%-2.87M
-131.69%-2.04M
-27.97%4.6M
-153.46%-2.15M
-76.80%688K
-Change in other current liabilities
-23.30%-434K
-245.93%-1.58M
-23.39%-422K
-215.08%-412K
-229.14%-390K
-146.19%-352K
32.03%1.08M
-138.30%-342K
-47.66%358K
-90.76%302K
-Change in other working capital
-349.07%-4.93M
-5.30%3.61M
203.83%2.09M
-113.48%-269K
-107.14%-188K
65.61%1.98M
-40.60%3.81M
-171.26%-2.01M
12.84%2M
848.01%2.63M
Cash from discontinued investing activities
Operating cash flow
198.39%9.87M
177.41%28.63M
914.84%20.04M
321.94%18.43M
101.76%182K
50.59%-10.03M
21.36%-36.98M
-73.56%1.98M
43.16%-8.31M
24.71%-10.35M
Investing cash flow
Cash flow from continuing investing activities
-2,400.00%-325K
-114.25%-696K
-103.32%-333K
-100.72%-71K
-106.06%-279K
99.93%-13K
181.33%4.88M
-32.63%10.02M
-32.35%9.91M
-45.54%4.6M
Capital expenditure reported
-2,400.00%-325K
19.82%-696K
-51.36%-333K
18.39%-71K
29.72%-279K
92.07%-13K
61.64%-868K
-66.67%-220K
74.78%-87K
74.35%-397K
Net investment purchase and sale
----
--0
--0
--0
--0
--0
253.73%5.75M
-31.76%10.24M
-33.33%10M
-50.00%5M
Cash from discontinued investing activities
Investing cash flow
-2,400.00%-325K
-114.25%-696K
-103.32%-333K
-100.72%-71K
-106.06%-279K
99.93%-13K
181.33%4.88M
-32.63%10.02M
-32.35%9.91M
-45.54%4.6M
Financing cash flow
Cash flow from continuing financing activities
-181.70%-8.84M
-68.51%11.39M
-166.83%-266K
16,786.75%13.85M
42.94%942K
-108.91%-3.14M
2,342.28%36.17M
132.25%398K
-15.28%-83K
18.53%659K
Net issuance payments of debt
----
--0
--0
--0
--0
--0
--38.17M
--0
--0
--0
Net common stock issuance
-21.08%-9.68M
54.23%-1.71M
4,694.58%7.63M
-475.90%-478K
-1,586.27%-860K
-132.91%-8M
-270.07%-3.73M
-238.78%-166K
-15.28%-83K
-104.00%-51K
Proceeds from stock option exercised by employees
-82.58%847K
655.80%13.1M
-1,499.47%-7.89M
--14.33M
153.80%1.8M
959.04%4.86M
198.28%1.73M
--564K
--0
22.20%710K
Cash from discontinued financing activities
Financing cash flow
-181.70%-8.84M
-68.51%11.39M
-166.83%-266K
16,786.75%13.85M
42.94%942K
-108.91%-3.14M
2,342.28%36.17M
132.25%398K
-15.28%-83K
18.53%659K
Net cash flow
Beginning cash position
51.91%115.06M
5.68%75.74M
50.93%95.62M
2.55%63.41M
-6.50%62.56M
5.68%75.74M
-43.26%71.67M
25.28%63.36M
22.20%61.83M
20.93%66.92M
Current changes in cash
105.37%708K
866.07%39.32M
56.95%19.44M
2,010.81%32.21M
116.61%845K
-176.97%-13.18M
107.45%4.07M
-41.30%12.39M
5,751.85%1.53M
-7.39%-5.09M
End cash Position
85.05%115.77M
51.91%115.06M
51.91%115.06M
50.93%95.62M
2.55%63.41M
-6.50%62.56M
5.68%75.74M
5.68%75.74M
25.28%63.36M
22.20%61.83M
Free cash flow
195.03%9.55M
173.79%27.93M
1,023.08%19.71M
318.79%18.36M
99.10%-97K
50.93%-10.04M
23.21%-37.85M
-76.09%1.76M
43.88%-8.39M
29.73%-10.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 198.39%9.87M177.41%28.63M914.84%20.04M321.94%18.43M101.76%182K50.59%-10.03M21.36%-36.98M-73.56%1.98M43.16%-8.31M24.71%-10.35M
Net income from continuing operations 124.23%2.23M101.01%554K316.72%11.08M103.95%621K87.15%-1.93M51.42%-9.22M11.92%-54.84M61.81%-5.11M-29.12%-15.74M24.38%-15.01M
Operating gains losses -------------------------97.07%83K------------
Depreciation and amortization 2.13%3.21M0.54%12.69M2.04%3.2M2.08%3.19M0.32%3.16M-2.21%3.14M-4.07%12.63M-3.87%3.13M-6.94%3.12M-6.21%3.15M
Deferred tax ------0--0--0--0--0-81.59%-2.27M--0-592.44%-3.32M210.96%749K
Other non cash items 5.33%889K359.86%3.37M-4.52%866K120.10%843K298.06%820K130.21%844K51.48%-1.3M170.80%907K206.09%383K192.79%206K
Change In working capital 93.47%-603K-17.46%-10.36M21.31%-373K810.39%6.14M-103.19%-6.88M-64.05%-9.24M-40.13%-8.82M-102.71%-474K106.08%674K-398.68%-3.39M
-Change in receivables 11.33%-5.25M-773.15%-10.64M273.58%2.7M-153.99%-703K-33.66%-6.72M-431.74%-5.92M85.44%-1.22M-89.32%723K108.27%1.3M-891.50%-5.03M
-Change in inventory 123.53%851K-119.61%-19.29M-27.86%-4.01M-289.79%-4.09M-234.35%-7.57M-55.10%-3.62M40.68%-8.78M-123.91%-3.14M51.32%-1.05M69.53%-2.27M
-Change in prepaid assets -90.54%145K-25.34%-2.1M502.89%1.25M-2,496.74%-5.15M-3.91%270K182.51%1.53M-152.18%-1.67M-115.28%-311K-37.32%215K-86.31%281K
-Change in payables and accrued expense 414.01%9.01M1,062.43%19.62M-143.05%-1.98M880.17%16.76M1,021.66%7.72M44.65%-2.87M-131.69%-2.04M-27.97%4.6M-153.46%-2.15M-76.80%688K
-Change in other current liabilities -23.30%-434K-245.93%-1.58M-23.39%-422K-215.08%-412K-229.14%-390K-146.19%-352K32.03%1.08M-138.30%-342K-47.66%358K-90.76%302K
-Change in other working capital -349.07%-4.93M-5.30%3.61M203.83%2.09M-113.48%-269K-107.14%-188K65.61%1.98M-40.60%3.81M-171.26%-2.01M12.84%2M848.01%2.63M
Cash from discontinued investing activities
Operating cash flow 198.39%9.87M177.41%28.63M914.84%20.04M321.94%18.43M101.76%182K50.59%-10.03M21.36%-36.98M-73.56%1.98M43.16%-8.31M24.71%-10.35M
Investing cash flow
Cash flow from continuing investing activities -2,400.00%-325K-114.25%-696K-103.32%-333K-100.72%-71K-106.06%-279K99.93%-13K181.33%4.88M-32.63%10.02M-32.35%9.91M-45.54%4.6M
Capital expenditure reported -2,400.00%-325K19.82%-696K-51.36%-333K18.39%-71K29.72%-279K92.07%-13K61.64%-868K-66.67%-220K74.78%-87K74.35%-397K
Net investment purchase and sale ------0--0--0--0--0253.73%5.75M-31.76%10.24M-33.33%10M-50.00%5M
Cash from discontinued investing activities
Investing cash flow -2,400.00%-325K-114.25%-696K-103.32%-333K-100.72%-71K-106.06%-279K99.93%-13K181.33%4.88M-32.63%10.02M-32.35%9.91M-45.54%4.6M
Financing cash flow
Cash flow from continuing financing activities -181.70%-8.84M-68.51%11.39M-166.83%-266K16,786.75%13.85M42.94%942K-108.91%-3.14M2,342.28%36.17M132.25%398K-15.28%-83K18.53%659K
Net issuance payments of debt ------0--0--0--0--0--38.17M--0--0--0
Net common stock issuance -21.08%-9.68M54.23%-1.71M4,694.58%7.63M-475.90%-478K-1,586.27%-860K-132.91%-8M-270.07%-3.73M-238.78%-166K-15.28%-83K-104.00%-51K
Proceeds from stock option exercised by employees -82.58%847K655.80%13.1M-1,499.47%-7.89M--14.33M153.80%1.8M959.04%4.86M198.28%1.73M--564K--022.20%710K
Cash from discontinued financing activities
Financing cash flow -181.70%-8.84M-68.51%11.39M-166.83%-266K16,786.75%13.85M42.94%942K-108.91%-3.14M2,342.28%36.17M132.25%398K-15.28%-83K18.53%659K
Net cash flow
Beginning cash position 51.91%115.06M5.68%75.74M50.93%95.62M2.55%63.41M-6.50%62.56M5.68%75.74M-43.26%71.67M25.28%63.36M22.20%61.83M20.93%66.92M
Current changes in cash 105.37%708K866.07%39.32M56.95%19.44M2,010.81%32.21M116.61%845K-176.97%-13.18M107.45%4.07M-41.30%12.39M5,751.85%1.53M-7.39%-5.09M
End cash Position 85.05%115.77M51.91%115.06M51.91%115.06M50.93%95.62M2.55%63.41M-6.50%62.56M5.68%75.74M5.68%75.74M25.28%63.36M22.20%61.83M
Free cash flow 195.03%9.55M173.79%27.93M1,023.08%19.71M318.79%18.36M99.10%-97K50.93%-10.04M23.21%-37.85M-76.09%1.76M43.88%-8.39M29.73%-10.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, the U.S. military launched retaliatory airs Show More